Elsevier at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
Elsevier takes part in 2 sessions at BioTechX Europe 2026 in Basel, and exhibits at Booth 328. Its program centres on making AI agents in drug discovery dependable by grounding them in trusted scientific data. It covers rules for anchoring agents to a common vocabulary of defined terms, and connectors that feed them chemistry, safety and pharmacokinetic data, which shows how the body handles a drug.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
Elsevier Amsterdam, Netherlands | |
Scientific and health information company offering evidence-based content and AI-enabled digital tools for pharmaceutical and biotech R&D. | Booth Exhibiting at Booth 328 Keynote Tue Oct 6 09:20 Semantic Layer or Silent Failure: Evidence-Based Rules for Grounding Agentic Workflows in Drug Discovery AI & large language modelsData integration & FAIR Talk Tue Oct 6 12:05 Making agentic workflows in drug discovery dependable with chemistry, pharmacokinetics, and safety data connectors How cleaned, consistently labeled data on chemistry, safety and how the body processes drugs makes AI drug discovery assistants more dependable. |
Instantly find 20 buyers from Elsevier
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction